96 related articles for article (PubMed ID: 19276660)
1. RNA interference of MBD1 in BxPC-3 human pancreatic cancer cells delivered by PLGA-poloxamer nanoparticles.
Luo G; Jin C; Long J; Fu D; Yang F; Xu J; Yu X; Chen W; Ni Q
Cancer Biol Ther; 2009 Apr; 8(7):594-8. PubMed ID: 19276660
[TBL] [Abstract][Full Text] [Related]
2. PLGA/poloxamer nanoparticles loaded with EPAS1 siRNA for the treatment of pancreatic cancer in vitro and in vivo.
Pan X; Zhu Q; Sun Y; Li L; Zhu Y; Zhao Z; Zuo J; Fang W; Li K
Int J Mol Med; 2015 Apr; 35(4):995-1002. PubMed ID: 25672594
[TBL] [Abstract][Full Text] [Related]
3. [Activation of multiple tumor suppressor genes by MBD1 siRNA in pancreatic cancer cell line BxPC-3].
Xu J; Liu C; Yu XJ; Jin C; Fu DL; Ni QX
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1948-51. PubMed ID: 19062732
[TBL] [Abstract][Full Text] [Related]
4. Proteomic analysis of differential proteins in pancreatic carcinomas: Effects of MBD1 knock-down by stable RNA interference.
Liu C; Chen Y; Yu X; Jin C; Xu J; Long J; Ni Q; Fu D; Jin H; Bai C
BMC Cancer; 2008 Apr; 8():121. PubMed ID: 18445260
[TBL] [Abstract][Full Text] [Related]
5. MBD1 is an Epigenetic Regulator of KEAP1 in Pancreatic Cancer.
Zhang B; Xu J; Li C; Shi S; Ji S; Xu W; Liu J; Jin K; Liang D; Liang C; Liu L; Liu C; Qin Y; Yu X
Curr Mol Med; 2016; 16(4):404-11. PubMed ID: 26980696
[TBL] [Abstract][Full Text] [Related]
6. Silencing of MBD1 and MeCP2 in prostate-cancer-derived PC3 cells produces differential gene expression profiles and cellular phenotypes.
Yaqinuddin A; Abbas F; Naqvi SZ; Bashir MU; Qazi R; Qureshi SA
Biosci Rep; 2008 Dec; 28(6):319-26. PubMed ID: 18666890
[TBL] [Abstract][Full Text] [Related]
7. A study of the suppressive effect on human pancreatic adenocarcinoma cell proliferation and angiogenesis by stable plasmid-based siRNA silencing of c-Src gene expression.
Zhao X; Li DC; Zhao H; Li Z; Wang JX; Zhu DM; Zhou J; Cen JN
Oncol Rep; 2012 Mar; 27(3):628-36. PubMed ID: 22200682
[TBL] [Abstract][Full Text] [Related]
8. Magnetic gold nanoparticle-mediated small interference RNA silencing Bag-1 gene for colon cancer therapy.
Huang W; Liu Z; Zhou G; Tian A; Sun N
Oncol Rep; 2016 Feb; 35(2):978-84. PubMed ID: 26717967
[TBL] [Abstract][Full Text] [Related]
9. Silencing of MBD1 reverses pancreatic cancer therapy resistance through inhibition of DNA damage repair.
Xu J; Zhu W; Xu W; Cui X; Chen L; Ji S; Qin Y; Yao W; Liu L; Liu C; Long J; Li M; Yu X
Int J Oncol; 2013 Jun; 42(6):2046-52. PubMed ID: 23588667
[TBL] [Abstract][Full Text] [Related]
10. [Transfection of pancreatic cancer cells BxPC-3 with recombinant plasmid pSilencer4.1-CMV neo-hTERT-siRNA and its silencing effects].
Tan J; Sun M; Mo XH; Lu QY; Zhou XH
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Aug; 30(8):1847-50. PubMed ID: 20813682
[TBL] [Abstract][Full Text] [Related]
11. Zinc finger E-box-binding homeobox 1 mediates aerobic glycolysis
Xu WY; Hu QS; Qin Y; Zhang B; Liu WS; Ni QX; Xu J; Yu XJ
World J Gastroenterol; 2018 Nov; 24(43):4893-4905. PubMed ID: 30487699
[TBL] [Abstract][Full Text] [Related]
12. Methylated DNA-binding domain 1 and methylpurine-DNA glycosylase link transcriptional repression and DNA repair in chromatin.
Watanabe S; Ichimura T; Fujita N; Tsuruzoe S; Ohki I; Shirakawa M; Kawasuji M; Nakao M
Proc Natl Acad Sci U S A; 2003 Oct; 100(22):12859-64. PubMed ID: 14555760
[TBL] [Abstract][Full Text] [Related]
13. Co-delivery of docetaxel and Poloxamer 235 by PLGA-TPGS nanoparticles for breast cancer treatment.
Tang X; Liang Y; Feng X; Zhang R; Jin X; Sun L
Mater Sci Eng C Mater Biol Appl; 2015 Apr; 49():348-355. PubMed ID: 25686959
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of ribosomal protein L39 by RNA interference inhibits the growth of human pancreatic cancer cells in vitro and in vivo.
Li C; Chen D; Luo M; Ge M; Zhu J
Biotechnol J; 2014 May; 9(5):652-63. PubMed ID: 24799381
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of DACH1 activity by short hairpin RNA represses cell proliferation and tumor invasion in pancreatic cancer.
Bu XN; Qiu C; Wang C; Jiang Z
Oncol Rep; 2016 Aug; 36(2):745-54. PubMed ID: 27278537
[TBL] [Abstract][Full Text] [Related]
16. Engineering of siRNA loaded PLGA Nano-Particles for highly efficient silencing of GPR87 gene as a target for pancreatic cancer treatment.
Ceylan S; Bahadori F; Akbas F
Pharm Dev Technol; 2020 Sep; 25(7):855-864. PubMed ID: 32188321
[TBL] [Abstract][Full Text] [Related]
17. Treatment of primary and metastatic breast and pancreatic tumors upon intravenous delivery of a PRDM14-specific chimeric siRNA/nanocarrier complex.
Taniguchi H; Natori Y; Miyagi Y; Hayashi K; Nagamura F; Kataoka K; Imai K
Int J Cancer; 2021 Aug; 149(3):646-656. PubMed ID: 33783816
[TBL] [Abstract][Full Text] [Related]
18. Effect of antisense MBD1 gene eukaryotic expression plasmid on expression of MBD1 gene in human biliary tract carcinoma cells.
Zuo S; Zou S; Luo J; Guo W; Xu L; Dong J; Liu M
J Huazhong Univ Sci Technolog Med Sci; 2005; 25(6):658-61. PubMed ID: 16696318
[TBL] [Abstract][Full Text] [Related]
19. Effect of PPM1H on malignant phenotype of human pancreatic cancer cells.
Zhu H; Qin H; Li DM; Liu J; Zhao Q
Oncol Rep; 2016 Nov; 36(5):2926-2934. PubMed ID: 27599670
[TBL] [Abstract][Full Text] [Related]
20. Methyl-CpG binding domain proteins and their involvement in the regulation of the MAGE-A1, MAGE-A2, MAGE-A3, and MAGE-A12 gene promoters.
Wischnewski F; Friese O; Pantel K; Schwarzenbach H
Mol Cancer Res; 2007 Jul; 5(7):749-59. PubMed ID: 17634428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
